Advertisement

Topics

Details on surprise Novartis heart drug success due Aug 27

23:27 EDT 28 Jun 2017 | Reuters

LONDON (Reuters) - Full details on the surprise success of a Novartis anti-inflammatory drug in cutting cardiovascular risk for heart attack survivors will be presented at a medical meeting on Aug. 27, conference organizers said on Thursday.

Original Article: Details on surprise Novartis heart drug success due Aug 27

NEXT ARTICLE

More From BioPortfolio on "Details on surprise Novartis heart drug success due Aug 27"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...